Amgen
AMGN
#102
Rank
ยฃ117.50 B
Marketcap
ยฃ218.54
Share price
-1.52%
Change (1 day)
-14.15%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

EPS for Amgen (AMGN)

EPS in 2025 (TTM): ยฃ8.46

According to Amgen's latest financial reports the company's current EPS (TTM) is ยฃ8.26. In 2024 the company made an earnings per share (EPS) of ยฃ5.69 a decrease over its 2023 EPS that were of ยฃ9.38.

EPS history for Amgen from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ8.4648.66%
2024ยฃ5.69-39.33%
2023ยฃ9.383.12%
2022ยฃ9.1017.57%
2021ยฃ7.74-16.38%
2020ยฃ9.26-4.32%
2019ยฃ9.682.05%
2018ยฃ9.48382.51%
2017ยฃ1.96-74.52%
2016ยฃ7.7112.66%
2015ยฃ6.8434.9%
2014ยฃ5.070.74%
2013ยฃ5.0420.36%
2012ยฃ4.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.04-87.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ2.00-75.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ1.17-85.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ3.57-56.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ7.59-8.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.76-78.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ6.77-17.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
-ยฃ4.52-154.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ9.23 11.82%๐Ÿ‡บ๐Ÿ‡ธ USA